CADDAC_logo-FULL-tagline-ENG
CADDAC_logo-FULL-ENG

New BC PharmaCare Coverage Discriminatory to Adults with ADHD

23/12/2016
Echeta Okeke

New BC PharmaCare Coverage Discriminatory to Adults with ADHD

On April 18th BC PharmaCare announced that it was expanding its existing coverage of medications for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) in the paediatric population only. Three long acting ADHD medications (Adderall XR, Vyvanse and Strattera) will be added under the Special Authority (SA) program. CADDRA and CADDAC along with BC medical practitioners welcome these expanded medication options for children. However, British Columbia continues to lag significantly behind other provinces by denying coverage to individuals over 19, thereby discriminating against adults with ADHD.

Read More on our Blog
May 2, 2017 Media Release

linkedin facebook pinterest youtube rss twitter instagram facebook-blank rss-blank linkedin-blank pinterest youtube twitter instagram